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ScienceDirectDendritic cells (DCs) are versatile controllers of the immune
system, best known for their potent ability to initiate adaptive
immunity. Traditionally, DCs have been defined on the basis of
cell morphology, expression of specific markers and select
functional attributes such as the ability to migrate to T cell areas
of secondary lymphoid organs and activate T lymphocytes.
However, such properties are not qualitative and often change
in conditions of inflammation or infection. Phenotypic-based
and function-based definitions can therefore lead to difficulties
in cell identification. Here we review other approaches to try
and solve questions of DC lineage attribution with an emphasis
on recent insights arising from our increased understanding of
DC ontogeny and differentiation.
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What is in a name?
DCs were originally identified by Steinman and Cohn in
mouse spleen on the basis of their unique morphology,
which distinguished them from macrophages [1]. They
were subsequently found to be the most potent stimu-
lators of the mixed lymphocyte reaction [2], setting the
foundation for decades of research demonstrating the
importance of DCs in initiating adaptive immune
responses. The name dendritic cell has become synon-
ymous with motile cells of stellate morphology, expres-
sing high levels of major histocompatibility complex class
II molecules and the integrin CD11c [3,4], distinguished
by their ability to migrate from non-lymphoid to lym-
phoid organs and their superior capacity to stimulate T
lymphocytes [5–7]. This has been subsumed into the
notion that DCs can be defined by their ability to migrate
to secondary lymphoid tissues and prime T cells. Thiswww.sciencedirect.com definition is useful but excludes the possibility that, in
some instances, T cell priming may be carried out by
monocytes or macrophages. It also glosses over the fact
that DCs are a heterogeneous family of cells, subsets of
which may in fact function to suppress rather than stimu-
late immune responses [8]. Finally, it ignores the point
that, in some situations, DCs orchestrate innate immune
responses independently of T cell activation or migration
to secondary lymphoid organs [9,10,11,12,13].
These anomalies, allied to the lack of unique phenotypic
markers that allow for unambiguous distinction of DCs
from monocytes and macrophages, have led some to
question the existence of DCs as an independent cell
type with unique functional properties [14–16]. So, how
can we circumvent these issues and define DCs other
than by phenotype or function? Recent efforts to charac-
terize DC precursors in mouse and human, hand-in-hand
with parallel studies on the ontogeny of macrophages and
monocytes [17,18,19,20,21,22,23,24,25], have
suggested that DCs can be grouped together based on
common descendence from a committed hematopoietic
progenitor. Such an ontogenetic perspective allows for
definition of DCs as a discrete hematopoietic lineage
independently of cell phenotype or function, thereby
permitting the unfettered exploration of DC roles in
immunity and homeostasis [26].
Ontogeny of DCs
The classic model of DC development is primarily
derived from mouse studies. A bipotent progenitor in
the bone marrow, called macrophage and DC precursor
(MDP), gives rise to DCs and monocytes [27–29]. MDPs
further differentiate into common DC precursors (CDPs)
restricted to the generation of plasmacytoid DCs (pDCs)
and conventional DCs (cDCs) [30,31]. While pDCs term-
inally differentiate in the bone marrow [32], so called pre-
DCs exit the bone marrow and migrate through the blood
to lymphoid and non-lymphoid organs, where they term-
inally differentiate into cDCs, including the CD8a+/
CD103+ and CD11b+ subsets [33,34]. Analogous to the
CDP, a common monocyte progenitor (cMoP) has
recently been identified that is downstream of MDPs
and gives rise to monocytes but not DCs [18].
Mouse MDPs express CX3CR1 and were originally
identified for their ability to generate DCs and monocytes
in vitro, as well as after transfer into mice [27–29].
Although evidence for MDP bi-potentiality was provided
in those early studies [27], it has been put in question
more recently [22]. Additionally, ‘MDP’ populations
now appear to exhibit substantial granulocyte potential
[22], which was not observed in the earlier studiesCurrent Opinion in Immunology 2015, 32:13–20
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Therefore, the existence of a bi-potential progenitor for
DCs and monocytes has become a subject of contention.
Added to this, CDPs, the presumed downstream devel-
opmental intermediate between MDPs and DCs, can
produce pDCs [30,31]. By contrast, MDPs exhibit pDC
potential in some [18,29] but not other [27,28] studies.
While these inconsistencies might be explained by dis-
parities in cell purity after isolation they also indicate that
MDPs might not always be developmental precursors of
pDCs. Indeed, tracking of bar-coded progenitors trans-
ferred into irradiated mice indicates that lineage diver-
gence among myeloid cell types might occur as early as a
stage upstream of MDPs known as the lymphoid-primed
multipotent progenitor (LMPP) [20].
Mouse MDPs and CDPs exhibit substantial phenotypic
overlap [29]. They both lack lineage specifying markers,
express CD115 and CD135 in addition to CX3CR1 and
can only be distinguished by the fact that CDPs express
lower levels of CD117 (c-kit) than MDPs [27–31]. We
have recently demonstrated that DNGR-1 (encoded by
the Clec9a gene and also known as CLEC9A) marks cells
resembling CDPs but not MDPs. DNGR-1+ CDPs exhi-
bit cDC-restricted differentiation potential and do not
generate pDCs after adoptive transfer [21] or in vitro
culture with Flt3L (BUS and CRS, unpublished obser-
vations). DNGR-1+ CDP express CD115, consistent with
the recent demonstration that CD115+ CDPs exhibit a
strong clonal bias to generate cDCs, whereas pDCs arise
predominantly from CD115 negative CDPs [19]. Thus,
cDCs and pDCs appear to have distinct immediate pro-
genitors, which can be distinguished by expression of
CD115 [19] and DNGR-1 [21]. Some CD115+ CDP,
which presumably express DNGR-1 [21], have com-
bined cDC and pDC potential in clonal assays [19,30,31],
although the interpretation of such experiments might be
marred by the reported in vitro developmental plasticity
of differentiating DCs [35]. Altogether, these data can be
integrated into a revised map of DC differentiation that
takes into account the fact that cDCs, pDCs and mono-
cytes develop as distinct lineages although the exact
developmental intermediates and branching points
remain to be clarified and may display considerable
plasticity (Figure 1).
Lineage attribution based on growth factor
requirements
Dependence on FLT3L is sometimes used as evidence
that a given leukocyte should be considered a member of
the DC lineage [36–38]. This is because FLT3L strongly
expands pDCs and cDCs in vivo [28,39,40] and can be
used to generate all functional subsets of DCs in vitro
[41]. Conversely, mice lacking Flt3L display a severe
deficiency in DCs, which is also apparent, although to a
lesser extent, in mice lacking its receptor CD135 (Flt3)
[42] or treated with CD135 inhibitors [43,44]. GM-CSF,Current Opinion in Immunology 2015, 32:13–20 on the other hand, is extensively used to differentiate
monocytes into cells resembling DCs in vitro [45] but
mice lacking GM-CSF or its receptor have normal de-
velopment of monocyte-derived cells [46] as well as
lymphoid tissue DCs [28,47]. Instead, they exhibit a
specific reduction of cDCs in many, but not all, non-
lymphoid tissues [46,48–50]. The GM-CSF dependence
of CD103+ cDCs is stronger than that of CD11b+ cDCs
[46] although the extent of reduction relates to the
markers used for cell identification [46,49], possibly
because GM-CSF regulates CD103 expression [51].
FLT3L and GM-CSF have also been implicated in the
development of human DCs [38,52–55].
Although FLT3L deficiency impacts DC numbers, the
cells that do develop in its absence are functional [42].
Transfer of DCs into a FLT3L-deficient environment
reduces their homeostatic proliferation [28] suggesting
that FLT3L controls peripheral expansion of DCs rather
than development. Consistent with that notion, CD135
deficiency has little effect on the number of MDPs in
bone marrow and preDCs in spleen [28]. By contrast,
preDC frequencies are reduced in non-lymphoid organs
of FLT3L deficient mice [36] and CDP numbers also
appear affected, although the reported reduction ranges
from two-fold [50] to near complete absence [22] and is
further amplified in the absence of GM-CSF [50]. These
results are difficult to interpret as FLT3L-deficient mice
exhibit abnormalities in various other hematopoietic
lineages, including B, T and NK cells [42]. Thus, the
exact role of FLT3L in DC development will benefit
from the identification of additional receptors for the
cytokine and improved genetic tools, such as floxed
FLT3 alleles.
Despite being incomplete, FLT3L dependence can still
be a useful surrogate for CDP origin. However, a cau-
tionary note is warranted. Even though steady state
monocyte development in mice appears FLT3L-inde-
pendent [42], FLT3L might influence monocyte devel-
opment into cells that resemble DCs. Indeed, addition of
FLT3L to human monocytes cultured in GM-CSF and
IL-4 increases the yield of DC-like cells with potent T
cell stimulatory capacity [56]. Murine monocytes cultured
with FLT3L alone do not become superior stimulators of
a mixed lymphocyte reaction [57] but the possibility
remains that FLT3L might promote monocyte differen-
tiation into DC-like cells during inflammation in vivo,
which to our knowledge has not been sufficiently
addressed in FLT3L or CD135 deficient animals.
Additionally, Langerhans cells (LC), which arise from
embryonic progenitors [58,59] and are therefore ontogen-
etically distinct from DCs, upregulate CD135 expression
upon migration to lymph nodes [60]. Thus, despite their
separate ontogeny, FLT3L could help monocytes and
LCs assume phenotypic and functional properties gener-
ally associated with DCs.www.sciencedirect.com
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Understanding DC development. Recent data suggest that cDCs, pDCs and monocytes arise via distinct developmental pathways and cellular
intermediates. The exact branching points are unclear but lineage imprinting may occur as early as LMPPs, potentially involving epigenetic
modifications, indicated by coloured nuclei. The existence of MDP or a common precursor for cDCs and pDCs is debatable. However, cDC-
restricted progenitors (‘cDC-P’) can be distinguished from pDC specific progenitors (pre-pDCs) by expression of CD115 and DNGR-1. cDC-Ps
further differentiate into pre-DCs, which acquire CD11c and Zbtb46 expression and travel through the blood to peripheral organs. Their
differentiation into CD8a+/CD103+ and CD11b+ cDCs in target tissues is controlled by the transcription factors Batf3 and IRF-4, respectively. pDC
differentiation from pre-pDC is controlled by E2-2 and occurs in the bone marrow. Mature pDCs then enter the blood to seed peripheral organs.
Monocytes also develop in the bone marrow and arise from common monocyte progenitors (cMoP), distinguished from cDC-P and pre-pDC by
lack of DNGR-1 and CD135 expression and by expression of Ly6C. Monocytes travel via the blood to peripheral organs where they can further
change their phenotype and function depending on environmental cues, such as inflammation (monocyte-derived cells).
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factors
Demonstrating that the development of a given DC
subset requires specific transcription factors has been a
powerful way to establish the existence of functionally
distinct DC subtypes. We can, for example, distinguish
pDCs from cDCs based on the finding that the devel-
opment of the former but not the latter is dependent on
E2-2 [61]. Among cDCs we can further discriminate two
main subtypes: CD8a+ cDCs in lymphoid organs and
their CD103+ counterparts in non-lymphoid tissues,
which depend on IRF8, Id2 and Batf3 [49,62–65], from
CD11b+ cDCs, which depend on RbpJ and IRF4
[12,66,67,68,69,70]. Notably, the same transcription
factors have been implicated in the development of the
likely-equivalent DC subsets in humans [61,71,72], indi-
cating that developmental programs are conserved across
species. The transcription factor Zbtb46 (zDC, Btbd4)
was identified for its prominent expression in mouse
preDCs and differentiated cDCs [37,73] but is absent
from pDCs or their precursors, as well as macrophages and
resting monocytes, making it a likely candidate regulator
of cDC development [37,73]. However, Zbtb46 turns out
to be dispensable for mouse cDC development [37,73]
even though it might influence DC subset composition
[74]. As Zbtb46 expression is also found in human DCs
[75,76], it can nevertheless be a useful marker to identify
DCs across species. But its use as lineage defining marker
requires caution as Zbtb46 is downregulated after DC
stimulation, induced in activated monocytes and
expressed in non-immune cells [37,73]. Interestingly,
rather than controlling lineage decisions, Zbtb46 appears
to function to reinforce a DC specific transcriptional
program [73] and suppress DC activation [74]. Notably,
mouse monocytes cultured in GM-CSF  IL-4,
uniformly upregulate Zbtb46 [73]. It will therefore be
important to determine whether Zbtb46 controls DC-
associated functional attributes of monocyte-derived
cells, such as antigen presentation [74].
Transcriptomic approaches to establish
lineage affiliations
Comparative gene expression analyses have identified
gene signatures specific to DCs and macrophages and thus
can clarify relationships among mononuclear phagocytes
[23,60,77]. Importantly, transcriptome profiling has
helped demonstrate the existence of the same two broad
subsets of cDCs across lymphoid and non-lymphoid tissues
of both mice and humans [26,38,63,69,77–80], as well as
other species, such as chicken, sheep and pig [81–83]. As
such, it is a powerful approach to defining cells, when
experimental manipulation is not straightforward or even
possible.
It is important to bear in mind that conclusions from
global gene expression analysis crucially depend on
the homogeneity of the analysed populations and theCurrent Opinion in Immunology 2015, 32:13–20 bioinformatics criteria utilized. For example, Clec9a has not
been associated with any DC signature [60] but instead
appears in a gene profile unique to red pulp macrophages
[77], which express negligible amounts of Clec9a mRNA and
no DNGR-1 protein (BUS and CRS, unpublished obser-
vations). Future studies might circumvent such limitations
through the profiling of single cells [84]. More importantly,
gene expression profiles might not always be indicative of
cell ontogeny. DCs and LCs that have immigrated to
lymphoid tissues exhibit striking similarities, independent
of tissue of origin [60]. Therefore, certain transcriptional
programs appear regulated by environmental cues rather
than cell ontogeny, raising the interesting question of
whether these programs reflect functional convergence
among phagocytes of distinct hematopoietic origin.
Lineage tracing
Answering the above question requires the development
of models allowing for in vivo tracing of phagocytes with
different origins [63]. By crossing mice expressing Cre
recombinase under the control of the Clec9a locus to
Rosa26-STOPflox-yellow fluorescent protein (YFP) repor-
ter mice, we have recently generated a genetic model
with which to fate map the progeny of DNGR-1+ CDP
and preDC [21]. Although Clec9a-Cre reporter mice
suffer from limitations, as DNGR-1 is also expressed
on CD8a+/CD103+ cDCs and to a lower extent on pDCs,
we were able to demonstrate YFP expression in DCs but
not monocytes or macrophages even after intestinal
inflammation and Listeria monocytogenes infection [21].
Importantly, using Clec9a-Cre reporter mice, we ident-
ified CDP-derived cells within CD64+ cell populations
previously thought to represent monocytes/macrophages
[21,85,86]. CD64+ CDP-derived cells are especially
frequent in kidneys, where they resemble yolk sac-
derived F4/80hi tissue-resident MØs, appear to lack
Zbtb46 expression [73] and where their affiliation as
DCs or macrophages has been debated [87]. The pre-
sence of a few YFP+ cells in the CD64 component of lung
and small intestine indicates the existence of these aty-
pical CDP-derived cells also in other tissues [21].
Notably, CD64+ kidney DCs stimulated naı¨ve T cells
in vitro, although less efficiently than CD11b+ cDCs
[21]. Thus, fate mapping of DC precursors reveals
previously unappreciated heterogeneity among mono-
nuclear phagocytes, raising the question of why cells of
distinct ontogeny but overlapping phenotype exist in the
same tissue. More detailed analyses of such atypical
CDP-derived cells, for instance by transcriptome profil-
ing, will contribute to elucidating their function and help
determine how it is shaped by the local environment.
Conclusion
The classification of DCs based on phenotypic and func-
tional properties that are often shared with other cell
types has led to difficulties in cell identification and even
debate over the existence of DCs as a discrete leukocytewww.sciencedirect.com
Defining dendritic cells Schraml and Reis e Sousa 17lineage. Phenotype-based and function-based definitions
are inherently problematic as functional roles and phe-
notypic markers often change under the influence of
environmental cues. While mononuclear phagocyte
classification may be considered a semantic issue, it is
key to scientific communication. It needs to be robust
enough to withstand arguments pertaining to levels of
surface marker expression or degree of T cell stimulatory
capacity to make it clearly accessible to all researchers
inside and outside the field. The identification of distinct
developmental precursors underscores that cDCs, pDCs
and monocytes constitute separate cell types and enables
a move towards cell classification based on ontogeny.
Importantly, ontogenetic definitions are independent of
functional or phenotypic properties, allowing the inves-
tigation of the full spectrum of phagocyte activity in an
unbiased manner. This freedom allows us for the first to
time to assess to what extent cellular properties are
dictated by ‘nurture’ versus ‘nature’. In other words it
allows us to determine which functions of tissue mono-
nuclear phagocyte subtypes are determined by ontogeny
and which are shaped in the local tissue environment.
Understanding DC ontogeny and refining cellular identi-
fication is a work in progress that will benefit from
improved genetic tools and techniques to analyse single
cells.
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